Springer Nature AG & Co. KGaA/€SPG
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA is a global academic publishing company specializing in research, health, and educational content. Formed in 2015 through the merger of Springer Science+Business Media and Holtzbrinck Publishing Group's Nature Publishing Group, Palgrave Macmillan, and Macmillan Education, the company publishes a wide array of scientific, technical, and medical journals under the Nature and Springer brands, as well as books and e-books across various disciplines. Headquartered in Berlin, Germany, with additional offices in London and New York City, Springer Nature operates in over 40 countries worldwide. The company has a significant presence in open access publishing, with 50% of its primary research articles published as open access in 2024, and continues to invest in technology and AI to enhance the publishing process. (,)
- Ticker
- €SPG
- Sector
- Communication
- Primary listing
- XETRA
- Employees
- 9,400
- Headquarters
- Berlin, Germany
- Website
- www.springernature.com
SPG Metrics
BasicAdvanced
€4.3B
13.01
€1.65
-
€0.83
3.87%
Price and volume
Market cap
€4.3B
52-week high
€22.00
52-week low
€14.72
Average daily volume
43K
Dividend rate
€0.83
Financial strength
Current ratio
0.921
Quick ratio
0.772
Long term debt to equity
0.707
Total debt to equity
0.718
Dividend payout ratio (TTM)
50.37%
Interest coverage (TTM)
5.30%
Profitability
EBITDA (TTM)
696.7
Gross margin (TTM)
86.96%
Net profit margin (TTM)
16.89%
Operating margin (TTM)
24.10%
Effective tax rate (TTM)
15.05%
Revenue per employee (TTM)
€210,000
Management effectiveness
Return on assets (TTM)
5.81%
Return on equity (TTM)
17.11%
Valuation
Price to earnings (TTM)
13.011
Price to revenue (TTM)
2.197
Price to book
2.14
Price to tangible book (TTM)
-2.13
Price to free cash flow (TTM)
9.604
Free cash flow yield (TTM)
10.41%
Free cash flow per share (TTM)
2.231
Dividend yield (TTM)
3.87%
Forward dividend yield
3.87%
Growth
Revenue change (TTM)
4.20%
Earnings per share change (TTM)
103.70%
What the Analysts think about SPG
Analyst ratings (Buy, Hold, Sell) for Springer Nature AG & Co. KGaA stock.
Analyst projections of the future price of Springer Nature AG & Co. KGaA stock.
Bulls say / Bears say
Springer Nature delivered 6.2% underlying revenue growth and 7.7% growth in adjusted operating profit in H1 2026, then raised its full-year revenue outlook to around 6%. This points to solid trading momentum and improving operating leverage. (Springer Nature Group)
Its Research business is growing faster than the market: published articles rose 13% against estimated market growth of around 8%, while nearly all 2026 contract renewals were retained. A growing open-access portfolio and new agreements with institutions support further growth. (Springer Nature Group)
Strong cash generation is helping reduce balance-sheet risk: free cash flow reached €268m in H1 and leverage fell to 1.6 times. Fitch affirmed the company’s BBB rating and revised its outlook to positive. (Springer Nature Group, Fitch Ratings)
The company says budget constraints are already affecting some research customers, while government savings could weigh on scientific publishing funding. That could limit growth if pressure spreads beyond individual markets. (Springer Nature Investor Relations)
Underlying operating profit grew, but adjusted EPS fell to €0.71 from €0.83 a year earlier. Less favourable currency effects and the loss of a prior-year tax benefit weakened the conversion of operating growth into shareholder earnings. (Springer Nature Group)
Rising book-integrity investigations could require more screening and review work, while putting trust in the catalogue under pressure. Springer Nature reported 210 book-related probes in 2025 and 81 by mid-April 2026. (Retraction Watch)
Data summarised monthly by Lightyear AI. Last updated on 26 Oct 2026.
SPG Financial Performance
Revenues and expenses
SPG Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing SPG
AllEURUSDGBP
Fund name | Fund size | €SPG weighting |
|---|---|---|
Vanguard Germany All Cap£VGER | €258M | 0.03% |
Vanguard ESG Developed Europe All Cap£V3EA | €125M | 0.01% |
Vanguard ESG Developed Europe All Cap£V3EL | €35M | 0.01% |
Vanguard FTSE Global All-cap$VALU | $199M | 0.00% |
Vanguard FTSE Global All-cap€VGLA | €171M | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.